Malignant ovarian germ cell tumors: Clinico-pathological presentation and survival outcomes

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 2, 2010, Pages 182-189

  Tangjitgamol, Siriwan ^a   Hanprasertpong, Jitti ^b   Manusirivithaya, Sumonmal ^a   Wootipoom, Virach ^b   Thavaramara, Thaovalai ^a   Buhachat, Rakchai ^b  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Chemotherapy; Conservative surgical treatment; Malignant ovarian germ cell tumor

Indexed keywords

TUMOR MARKER;

ABDOMINAL MASS; ADOLESCENT; ADULT; AGED; ARTICLE; CHEMOTHERAPY; CHILD; CONTROLLED STUDY; DYSGERMINOMA; FEMALE; FOLLOW UP; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY TUMOR; OVERALL SURVIVAL; PELVIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIOTHERAPY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; ALPHA-FETOPROTEINS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 76449114624     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016340903443684     Document Type: Article

References (30)

1. Chow SN, Yang JH, Lin YH, Chen YP, Lai JI, Chen RJ, et al. Malignant ovarian germ cell tumors. Int J Gynaecol Obstet. 1996;53:151-158
2. Sah SP, Uprety D, Rani S. Germ cell tumors of the ovary: a clinicopathologic study of 121 cases from Nepal. J Obstet Gynaecol Res. 2004;30:303-308
3. De Backer A, Madern GC, Oosterhuis JW, Hakvoort-Cammel FG, Hazebroek FW. Ovarian germ cell tumors in children: a clinical study of 66 patients. Pediatr Blood Cancer. 2006;46:459-464 (Pubitemid 43334652)
4. Brewer M, Gershenson DM, Herzog CE, Mitchell MF, Silva EG, Wharton JT. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol. 1999;17:2670-2675
5. Perrin LC, Low J, Nicklin JL, Ward BG, Crandon AJ. Fertility and ovarian function after conservative surgery for germ cell tumours of the ovary. Aust N Z J Obstet Gynaecol. 1999;39:243-245
6. Billmire D, Vinocur C, Rescorla F, Cushing B, London W, Schlatter M, et al. Children's Oncology Group (COG). Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg. 2004;39:424-429
7. El-Lamie IK, Shehata NA, Abou-Loz SK, El-Lamie KI. Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University. Eur J Gynaecol Oncol. 2000;21:605-609
8. Culine S, Lhomme C, Kattan J, Michel G, Duvillard P, Droz JP. Pure malignant immature teratoma of the ovary: the role of chemotherapy and second-look surgery. Int J Gynecol Cancer. 1995;5:432-437
9. Slayton RE, Park RC, Silverberg SG, Shingleton H, Creasman WT, Blessing JA. Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary: A Gynecologic Oncology Group Study (a final report). Cancer. 1985;56:243-248
10. Williams SD, Blessing JA, Moore DH, Homesley HD, Adcock L. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med. 1989;111:22-27
11. Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL, et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol. 1990;8:715-720
12. Tangjitgamol S, Manusirivithaya S, Leelahakorn S, Thawaramara T, Suekwatana P, Sheanakul C. The growing teratoma syndrome: a case report and a review of the literature. Int J Gynecol Cancer. 2006;16(Suppl 1):384-390
13. Patterson DM, Murugaesu N, Holden L, Seckl MJ, Rustin GJ. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer. 2008;18:43-50.
14. Skof E, Grasic Kuhar C, Cerar O, Zakotnik B. Survival and fertility of patients with malignant ovarian germ cell tumours. Eur J Gynaecol Oncol. 2004;25:702-706
15. Malone JM, Gershenson DM, Creasy RK, Kavanagh JJ, Silva EG, Stringer CA. Endodermal sinus tumor of the ovary associated with pregnancy. Obstet Gynecol. 1986;68 (3 Suppl):86-89
16. Robova H, Rob L, Hrehorcak M, Zoban P, Prusa R. Endodermal sinus tumor diagnosed in pregnancy: a case report. Int J Gynecol Cancer. 2007;17:914-916
17. Karimi Zarchi M, Behtash N, Modares Gilani M. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review. Arch Gynecol Obstet. 2008;277:75-78
18. Peccatori F, Bonazzi C, Chiari S, Landoni F, Colombo N, Mangioni C. Surgical management of malignant ovarian germ-cell tumors: 10 years experience of 129 patients. Obstet Gynecol. 1995;86:367-372
19. Boran N, Tulunay G, Caliskan E, Köse MF, Haberal A. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas. Arch Gynecol Obstet. 2005;271:104-108
20. Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol. 2007;25:2938-2943
21. Beiner ME, Gotlieb WH, Korach Y, Shrim A, Stockheim D, Segal Y, et al. Cystectomy for immature teratoma of the ovary. Gynecol Oncol. 2004;93:381-384
22. Bafna UD, Umadevi K, Kumaran C, Nagarathna DS, Shashikala P, Tanseem R. Germ cell tumors of the ovary: is there a role for aggressive cytoreductive surgery for nondysgerminomatous tumors? Int J Gynecol Cancer. 2001;11:300-304
23. Ayhan A, Bildirici I, Günalp S, Yuce K. Pure dysgerminoma of the ovary: a review of 45 well staged cases. Eur J Gynaecol Oncol. 2000;21:98-101.
24. Messing MJ, Gershenson DM, Morris M, Burke TW, Kavanagh JJ, Wharton JT. Primary treatment failure in patients with malignant ovarian germ cell neoplasms. Int J Gynecol Cancer. 1992;2:295-300.
25. Mitchell PL, Al-Nasiri N, A'Hern R, Fisher C, Horwich A, Pinkerton CR, et al. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer. 1999;85:2232-2244
26. Li J, Yang W, Wu X. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Gynecol Oncol. 2007;105: 769-775
27. Wu X, Han LY, Xu X, Li Z. Recurrent immature teratoma of the ovary: a case report of radical secondary cytoreduction with replacement of the aortic bifurcation. Gynecol Oncol. 2004;95:746-749
28. Lai CH, Chang TC, Hsueh S, Wu TI, Chao A, Chou HH, et al. Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol. 2005;96: 784-791
29. Kumar S, Shah JP, Bryant CS, Imudia AN, Cote ML, Ali-Fehmi R, et al. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol. 2008;110:125-132
30. Motzer RJ, Nichols CJ, Margolin KA, Bacik J, Richardson PG, Vogelzang NJ, et al. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol. 2007;25:247-256